See more : Tong Ren Tang Technologies Co. Ltd. (TGRNF) Income Statement Analysis – Financial Results
Complete financial analysis of Duearity AB (publ) (DEAR.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Duearity AB (publ), a leading company in the Medical – Devices industry within the Healthcare sector.
- Equinox Gold Corp. (EQX) Income Statement Analysis – Financial Results
- Loco Hong Kong Holdings Limited (8162.HK) Income Statement Analysis – Financial Results
- Dongwon Systems Corporation (014820.KS) Income Statement Analysis – Financial Results
- Barksdale Resources Corp. (2NZ.F) Income Statement Analysis – Financial Results
- Shenzhen Comix Group Co., Ltd. (002301.SZ) Income Statement Analysis – Financial Results
Duearity AB (publ) (DEAR.ST)
About Duearity AB (publ)
Duearity AB (publ), a medical technology company, engages in the development of Tinearity, a tinnitus aid. The company's Tinearity contains a small sound element that generates white noise directly into the ear via the skull. It also develops Tinearity AI, an artificial intelligence-based solution that would help people suffering from or bothered by tinnitus to take command and master their symptoms. The company was incorporated in 2020 and is based in Malmö, Sweden.
Metric | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 1.65M | 0.00 | 174.48K | 624.00 |
Cost of Revenue | 5.83M | 6.38M | 15.52M | 958.00K |
Gross Profit | -4.18M | -6.38M | -15.35M | -957.38K |
Gross Profit Ratio | -252.60% | 0.00% | -8,794.87% | -153,425.64% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 14.30M | 367.00K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 21.59M | 18.92M | 14.30M | 367.00K |
Other Expenses | 0.00 | 12.79M | 1.06M | 0.00 |
Operating Expenses | 21.59M | 12.79M | 15.36M | 367.00K |
Cost & Expenses | 27.42M | 19.17M | 15.36M | 1.33M |
Interest Income | 39.00K | 9.00K | 80.00K | 0.00 |
Interest Expense | 467.00K | 83.00K | 79.54K | 0.00 |
Depreciation & Amortization | 984.00K | 153.00K | 15.36M | 2.27M |
EBITDA | -24.74M | -19.01M | -80.00K | -1.33M |
EBITDA Ratio | -1,495.71% | 0.00% | -8,802.97% | -212,339.74% |
Operating Income | -25.76M | -19.17M | -15.36M | -1.33M |
Operating Income Ratio | -1,557.62% | 0.00% | -8,802.97% | -212,339.74% |
Total Other Income/Expenses | -427.00K | -73.00K | -80.05K | 0.00 |
Income Before Tax | -26.19M | -19.24M | -15.44M | -1.33M |
Income Before Tax Ratio | -1,583.43% | 0.00% | -8,848.56% | -212,339.74% |
Income Tax Expense | 0.00 | 74.00K | 79.54K | -2.27M |
Net Income | -26.19M | -19.31M | -15.52M | -1.33M |
Net Income Ratio | -1,583.43% | 0.00% | -8,894.15% | -212,339.74% |
EPS | -0.40 | -1.27 | -1.30 | -0.09 |
EPS Diluted | -1.41 | -1.27 | -1.30 | -0.09 |
Weighted Avg Shares Out | 65.05M | 15.20M | 11.89M | 14.00M |
Weighted Avg Shares Out (Dil) | 18.52M | 15.20M | 11.89M | 14.00M |
Source: https://incomestatements.info
Category: Stock Reports